1116 related articles for article (PubMed ID: 15866165)
21. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
22. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
Kato M; Patel MS; Levasseur R; Lobov I; Chang BH; Glass DA; Hartmann C; Li L; Hwang TH; Brayton CF; Lang RA; Karsenty G; Chan L
J Cell Biol; 2002 Apr; 157(2):303-14. PubMed ID: 11956231
[TBL] [Abstract][Full Text] [Related]
23. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.
Rodda SJ; McMahon AP
Development; 2006 Aug; 133(16):3231-44. PubMed ID: 16854976
[TBL] [Abstract][Full Text] [Related]
25. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.
Mbalaviele G; Sheikh S; Stains JP; Salazar VS; Cheng SL; Chen D; Civitelli R
J Cell Biochem; 2005 Feb; 94(2):403-18. PubMed ID: 15526274
[TBL] [Abstract][Full Text] [Related]
26. TSH is a negative regulator of skeletal remodeling.
Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
[TBL] [Abstract][Full Text] [Related]
27. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
28. Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical Wnt signaling.
Chen JR; Lazarenko OP; Wu X; Kang J; Blackburn ML; Shankar K; Badger TM; Ronis MJ
J Bone Miner Res; 2010 Nov; 25(11):2399-411. PubMed ID: 20499363
[TBL] [Abstract][Full Text] [Related]
29. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
Gilbert LC; Chen H; Lu X; Nanes MS
Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
[TBL] [Abstract][Full Text] [Related]
30. Cajanolactone A from
Liu S; Luo ZH; Ji GM; Guo W; Cai JZ; Fu LC; Zhou J; Hu YJ; Shen XL
Molecules; 2019 Jan; 24(2):. PubMed ID: 30642055
[TBL] [Abstract][Full Text] [Related]
31. TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro.
Hens JR; Wilson KM; Dann P; Chen X; Horowitz MC; Wysolmerski JJ
J Bone Miner Res; 2005 Jul; 20(7):1103-13. PubMed ID: 15940363
[TBL] [Abstract][Full Text] [Related]
32. Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development.
Gori F; Friedman LG; Demay MB
Dev Biol; 2006 Jul; 295(2):498-506. PubMed ID: 16730692
[TBL] [Abstract][Full Text] [Related]
33. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.
Chen Y; Whetstone HC; Lin AC; Nadesan P; Wei Q; Poon R; Alman BA
PLoS Med; 2007 Jul; 4(7):e249. PubMed ID: 17676991
[TBL] [Abstract][Full Text] [Related]
34. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
[TBL] [Abstract][Full Text] [Related]
35. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
[TBL] [Abstract][Full Text] [Related]
36. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
37. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts.
Liu G; Bafico A; Aaronson SA
Mol Cell Biol; 2005 May; 25(9):3475-82. PubMed ID: 15831454
[TBL] [Abstract][Full Text] [Related]
39. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
40. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
